Healthcare Pharmaceutical Biotech

Cosmos Health Secures Additional 2.5 Million Units Under New Five-Year Contract Manufacturing Agreement with Viofar; Total Orderbook Surpasses 27.5 Million Units

September 11, 2026 11:10 AM

Cosmos Health Inc. ("Cosmos Health" or the "Company") (NASDAQ:COSM), a diversified, vertically integrated global healthcare group, today announced that its wholly owned subsidiary, Cana Laboratories S.A. ("Cana"), has secured a new five-year contract manufacturing agreement with Viofar covering approximately 2.5 million units of ROSARTIA. The agreement represents approximately 500,000 contracted units annually and increases Cana's cumulative...

Read more

Tixel i Receives CE Certification, Expanding Access to TMA(R) Dry Eye Therapy Across Europe

September 11, 2026 10:20 AM

Novoxel® Ltd., developer of Tixel, today announced that Tixel i, its proprietary device for the treatment of dry eye disease, has received CE certification under EU Medical Device Regulation (MDR) certificate 725869, clearing the way for the device to be marketed and sold across the European Union. The certification allows eye care practitioners throughout Europe to offer the Tixel for Dry Eye procedure, a non-invasive, in-office treatment that...

Read more

From Paper to Pixels: How Digitalization in Healthcare Can Benefit Rural Communities

September 11, 2026 9:35 AM

Many remote communities lack access to quality healthcare for various reasons, a major one being the reliance on paper medical records. In Argentina, doctors struggled to keep track of patients' medical records to provide consistent care across vast distances. This compromised the quality of consultations, as records were often incomplete or scattered. Digitalization in healthcare can address these challenges and ensure personal data security....

Read more

Medical Care Technologies (OTCID:MDCE) Advances StrainScan Pro Into a Second Major Vertical: The $4 Trillion Foodservice Market

September 11, 2026 8:57 AM

Medical Care Technologies Inc. (OTCID:MDCE) today announced further progress on StrainScan Pro's foodservice application, advancing the platform from market positioning into a custom demonstration path for commercial kitchens and multi-unit operators. The platform is live at https://strainscanpro.com. Foodservice has already been identified as a core StrainScan Pro vertical alongside agriculture. The Company is now taking the same next step it...

Read more

Handa Oncology Receives FDA Final Approval for OMCAZIO(TM) (cabozantinib) Capsules

September 11, 2026 7:30 AM

Handa Pharmaceuticals, Inc. ("Handa" or the "Company") (TSE:6620) announced that the U.S. Food and Drug Administration ("FDA") has granted final approval to OMCAZIO™ (cabozantinib) capsules, the laurylsulfate salt formulation of cabozantinib developed by the Company's U.S. subsidiary, Handa Oncology, LLC. The action converts Handa's prior tentative approval to final approval and authorizes OMCAZIO for commercialization in the United States....

Read more

BALIMONT Details Global Expansion Strategy Built on 49 PCT Patent Assets

September 11, 2026 6:20 AM

BALIMONT, a UK-registered patented ingredient brand operating as the Microbiome & Immunity Ingredient Platform, today announced the next phase of its global development strategy. The proprietary ingredient portfolio is positioned within the broader life-science brand platform associated with the European Life Science Research Association (ELSRA), while BALIMONT focuses on international commercialization, business development and market...

Read more

Encision Completes $80,000 Private Placement

September 11, 2026 5:00 AM

Encision Inc. (OTC PINK:ECIA), a medical device company owning patented Active Electrode Monitoring (AEM®) Technology that prevents dangerous radiant energy burns in minimally invasive surgery, today announced that on September 8, 2026 it completed an $80,000 private placement of common stock with a group of private investors. "We are pleased to have secured necessary funds for general working capital purposes," said Robert Fries, Interim...

Read more

Society for Evidence-Based Gender Medicine to Host "Rethinking Youth Gender Medicine: Charting a Path Forward" Conference in Washington, D.C.

September 10, 2026 4:50 PM

On November 5-7, clinicians, researchers, academics, ethicists, and patient and parent advocates will gather in Washington, D.C., for "Rethinking Youth Gender Medicine: Charting a Path Forward," a three-day in-person and virtual conference hosted by the Society for Evidence-Based Gender Medicine (SEGM). The conference comes at a pivotal moment for pediatric gender medicine. Systematic evidence reviews have identified serious concerns about the...

Read more

Champions Oncology Reports Revenue of $15.2 Million

September 10, 2026 4:00 PM

Champions Oncology, Inc. (Nasdaq:CSBR), a leading translational oncology research organization, today announced its financial results for its first quarter of fiscal 2027, ended July 31, 2026. First Quarter and Recent Highlights: Revenue of $15.2 million, an increase of 8.8% year over year Oncology services margin of 51%, compared with 43% in the prior-year period Adjusted EBITDA of $671,000, compared with $59,000 in the prior-year period...

Read more

Ahead of 9/11, U.S. Veterans' Non-Profit Partners with World's Only Medically Licensed Ayahuasca Facility to Combat PTSD and Suicide

September 10, 2026 1:27 PM

Rythmia Life Advancement Center, the world's first medically licensed plant medicine retreat, has joined forces with The Coming Home Project, a veteran-founded 501(c)(3) nonprofit dedicated to ending veteran suicide through access to psychedelic-assisted healing. In the week of the 25th anniversary of 9/11, from September 5 to September 12, 2026, the two organizations are hosting an inaugural retreat week reserved exclusively for combat veterans...

Read more

State Marijuana Operators Denied Party Status in Schedule III Appeal as MMJ Challenge Moves Forward

September 10, 2026 12:15 PM

Two state marijuana operators seeking to defend the federal government's Schedule III marijuana order have been denied intervention as full parties in the litigation now pending before the United States Court of Appeals for the District of Columbia Circuit. In a September 9 order, the court denied a motion by MedPharm Iowa, LLC, doing business as Bud & Mary's, and Tri-Mountain Pure, LLC to intervene in the consolidated challenges to the federal...

Read more

Biopharma Circular Systems Will Move Beyond Park Benches

September 10, 2026 10:40 AM

The world only needs so many park benches. Back in 2015, we launched an industry-first biopharma recycling program to address the new and fast-growing challenge of single-use plastics. At the time, the industry was shifting away from stainless-steel manufacturing systems toward single-use technologies, such as disposable bioreactor bags, filters, and assemblies used to produce life-saving therapies. Sustainability drove this transition, even if...

Read more

ScienceSoft Predicts One in Ten US Medical Visits Will Be Virtual by 2030

September 10, 2026 10:35 AM

ScienceSoft has published a prediction article based on its proprietary research into the future of telemedicine adoption in the United States. Kate Lukina, MD, Hadeel Abu Baker, and Julia Lebedeva forecast that by 2030, one in ten U.S. medical visits could take place virtually, with gradual growth expected across mental health, endocrinology, obstetrics, and primary care. ScienceSoft Predicts One in Ten US Medical Visits Will Be Virtual by 2030...

Read more

Sacred Connection Launches Direct-Trade Amazonian Grounding Botanicals in the U.S. to Combat Modern Digital Burnout

September 10, 2026 10:00 AM

As remote work fatigue, screen overstimulation, and chronic stress reach record highs across North America, Sacred Connection today announced the official expansion of its direct-trade Amazonian botanical line into the U.S. market. To help modern professionals, meditators, and wellness practitioners break free from continuous digital noise, Sacred Connection offers authentic Hapé (pronounced ha-PAY), a sacred, ancestral botanical preparation...

Read more

Surmodics Opens Medical Device Coating Capabilities in Ireland

September 10, 2026 10:00 AM

Surmodics, Inc. today announced its expanded medical device coating capabilities in Galway, Ireland, expanding access to the company's Performance Coatings and coating services for medical device manufacturers throughout Ireland and Europe. The facility now includes dedicated cleanroom environments designed for medical device coating services and brings Surmodics' nearly 50 years of coating experience closer to one of the world's leading medical...

Read more

DistillerSR Launches Regulatory-Grade Smart Screening for Titles and Abstracts

September 10, 2026 10:00 AM

DistillerSR® Inc., the pioneer and market leader in AI-enabled literature review automation and evidence management, today announced the official launch of Smart Screening, a new capability that brings regulatory-grade GenAI to title and abstract screening within the DistillerSR platform. Smart Screening enables pharmaceutical, medical device, and research teams to accurately screen large volumes of abstracts automatically, with full...

Read more

The Longevity Centers of America Opens Central Florida Location in Orlando's Dr. Phillips Corridor

September 10, 2026 10:00 AM

The Longevity Centers of America (LCOA) is opening its first Central Florida location, a clinic in the Dr. Phillips corridor of southwest Orlando, extending its diagnostic-first model of care into a new region. The Orlando clinic is located at 6000 Turkey Lake Road, Suite 209, and is scheduled to open on September 28. Ahead of that date, the practice has started a waitlist for patients who want to reserve early appointments. The location is the...

Read more

New National Analysis Reveals Large Geographic Gaps in Detoxification Services

September 10, 2026 9:35 AM

A new national analysis from Treatment Locators found substantial geographic differences in the availability of addiction treatment facilities reporting detoxification services across the United States. Treatment Locators analyzed 11,513 facilities listed in Substance Abuse and Mental Health Services Administration data and identified 2,261 facilities - 19.6% - reporting detoxification services. Of those, 2,169 had usable geographic coordinates...

Read more

AGS Health Recognized With Brandon Hall Group Silver HCM Learning and Development Excellence Award

September 10, 2026 9:00 AM

AGS Health®, a leading technology-first revenue cycle management (RCM) solutions provider serving U.S. healthcare providers through a comprehensive platform combining AI-driven solutions, data analytics, and specialized global delivery capabilities, has been recognized with a Brandon Hall Group Silver HCM Learning and Development Excellence Award. The company was recognized in the Best Certification Program category for its talent development...

Read more

All Randomized Pediatric Patients to Continue in the Single-Blind Extension Phase of Jaguar Health's Pivotal Clinical Trial of Crofelemer for Microvillus Inclusion Disease (MVID) with Intestinal Failure (IF)

September 10, 2026 9:00 AM

Jaguar Health, Inc. (NASDAQ:JAGX) (Jaguar) family company Napo Pharmaceuticals (Napo) today announced that all randomized pediatric MVID patients in Napo's pivotal crossover clinical trial have entered the single-blind extension phase to receive blinded doses of crofelemer to support longer-term safety and efficacy for crofelemer powder for oral solution as adjunctive therapy to parenteral support (PS). The trial is ongoing at multiple centers...

Read more